Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...

Prolia is an injection given every 6 months to treat osteoporosis in men, postmenopausal women, and people who take corticosteroid medicines who are at high risk for fractures.It is also used to ...

Forteo is given as a self-injection once daily. But Prolia is given once every 6 months by a healthcare professional. There aren’t any studies that have compared these two drugs to each other.

Prolia, a monoclonal antibody administered every six months as a subcutaneous injection, was first approved in 2010 as a treatment for osteoporosis in postmenopausal women at high risk of fracture.